2018 Annual Meeting | PL11 - Invited Science: The Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative
| 01:00 PM - 01:05 PM | Luncheon |
Introduction
Walter J. Koroshetz, MD, FAAN |
| 01:05 PM - 01:25 PM | Speaker |
Full-scale Neuronal Network Modeling of Spatial Learning and Memory in Hippocampus
Ivan Soltesz, PhD |
| 01:25 PM - 01:45 PM | Speaker |
Non-degenerate multiphoton microscopy for deep brain imaging
Anna Devor, PhD |
| 01:45 PM - 02:05 PM | Speaker |
Defining Cell Types, Lineage, and Connectivity in Developing Human Cortex
Daniel H. Geschwind, MD, PhD |
| 02:05 PM - 02:25 PM | Speaker |
Using Tissue Clearing and Optogenetics to Dissect the Circuitry Underlying Neurological Disorders
Viviana Gradinaru, PhD |
| 02:25 PM - 02:30 PM | Closing Remarks |
Closing Remarks
|
| Walter J. Koroshetz, MD, FAAN | Dr. Koroshetz has nothing to disclose. |
| Sydney Cash, MD | Dr. Cash has received stock or an ownership interest from Beacon Biosignals. |
| Arnold R. Kriegstein, MD, PhD | No disclosure on file |
| Anna Devor, PhD | No disclosure on file |
| Viviana Gradinaru, PhD | Viviana Gradinaru, PhD has nothing to disclose. |
| Natalia S. Rost, MD, MPH, FAHA, FAAN | Dr. Rost has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for American Academy of Neurology. Dr. Rost has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care. |
| Daniel H. Geschwind, MD, PhD | Dr. Geschwind has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Ovid Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for AcuraStem, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axial Biotherapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Falcon Computing. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier-Biological Psychiatry. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NYAS. Dr. Geschwind has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Covington& Burling LLP. Dr. Geschwind has stock in none related to talk. The institution of Dr. Geschwind has received research support from CurePSP. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from Rainwater Charitable Foundation. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from The Simons Foundation. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NINDS. The institution of Dr. Geschwind has received research support from NIMH. The institution of Dr. Geschwind has received research support from NINDS/NIA. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from NIH/NINDS. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH/NIMH. The institution of Dr. Geschwind has received research support from Adelson Medical Research Foundation. The institution of Dr. Geschwind has received research support from U of Virginia and NIH/NIMH. The institution of Dr. Geschwind has received research support from NIH. The institution of Dr. Geschwind has received research support from NIH/NHGRI. The institution of Dr. Geschwind has received research support from NIH/NIMH. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. Dr. Geschwind has received intellectual property interests from a discovery or technology relating to health care. |
| Ivan Soltesz, PhD | No disclosure on file |
| Doris Tsao, PhD | No disclosure on file |